A key healthcare committee in the Iowa House of Representatives recently introduced a bill that would bar drug manufacturer restrictions [...] …
Year: 2024
Medicare administrative contractors (MACs) covering more than half the states have initiated lump sum repayments to 340B hospitals, after getting [...] …
An influential senator’s inquiry into the nation’s two largest 340B pharmacy chains comes amid growing scrutiny into 340B contract pharmacies [...] …
Pharmaceutical giant AbbVie recently urged a federal judge to rule on its suit against Louisiana’s 340B contract pharmacy law without [...] …
![](https://340breport.com/wp-content/uploads/2023/05/RxS-300x200-1.png)
Q: Tell us some interesting details about your company’s history.
Imagine a world where flip phones were the pinnacle of consumer technology – that’s the era when RxStrategies was founded.
…
The top Republican on an influential Senate committee yesterday asked the nation’s two largest contract pharmacy companies for detailed information [...] …
Two high-ranking West Virginia state senators recently introduced a bipartisan bill that would prohibit drug manufacturer restrictions on 340B contract [...] …
Drugmakers issued a record 41 refunds to 340B covered entities in 2023. And Merck is the first to announce it [...] …
SPONSORED CONTENT
In the complex landscape of healthcare, the 340B program plays a vital role in ensuring that vulnerable patients with limited financial resources have access to affordable medications. It enables qualified covered entities to maximize their resources and offer a wider range of benefits and services
…
Just days prior to implementing its first contract pharmacy restrictions, Japanese pharmaceutical giant Takeda yesterday announced it will increase the [...] …